Colleen Delaney
Directeur Technique/Scientifique/R&D chez COEPTIS THERAPEUTICS HOLDINGS, INC.
Fortune : - $ au 31/05/2024
Postes actifs de Colleen Delaney
Sociétés | Poste | Début | Fin |
---|---|---|---|
VICAPSYS LIFE SCIENCES, INC. | Directeur/Membre du Conseil | 22/09/2022 | - |
COEPTIS THERAPEUTICS HOLDINGS, INC. | Directeur Technique/Scientifique/R&D | 30/08/2023 | - |
American Society for Blood & Marrow Transplantation | Directeur/Membre du Conseil | - | - |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - | |
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Historique de carrière de Colleen Delaney
Anciens postes connus de Colleen Delaney
Sociétés | Poste | Début | Fin |
---|---|---|---|
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Corporate Officer/Principal | - | - |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Directeur Technique/Scientifique/R&D | - | - |
Fondateur | - | - |
Formation de Colleen Delaney
University of Oxford | Graduate Degree |
Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 9 |
Royaume-Uni | 2 |
2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sectorielle
Consumer Services | 4 |
Health Technology | 4 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
VICAPSYS LIFE SCIENCES, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center Miscellaneous Commercial ServicesCommercial Services Fred Hutchinson Cancer Research Center is a non-profit organization which provides research and testing services. The company was founded in 1965 and is headquartered in Seattle, WA. | Commercial Services |
American Society for Blood & Marrow Transplantation | |
Nohla Therapeutics, Inc.
Nohla Therapeutics, Inc. BiotechnologyHealth Technology Nohla Therapeutics, Inc. developed cellular therapies for hematological disorders. The firm's products used without the need for HLA matching and promote hematopoietic recovery in patients at risk for neutropenia after intensive chemotherapy and/or radiation treatment for critical diseases. The company was founded by Colleen Delaney and was headquartered in Seattle, WA. | Health Technology |
Deverra Therapeutics, Inc.
Deverra Therapeutics, Inc. BiotechnologyHealth Technology Deverra Therapeutics, Inc. engages in the development of platform technology for the generation of off-the-shelf allogeneic cellular immunotherapies. It offers a notch-mediated cell expansion platform for the production of progenitor blood and immune cells for clinical application. The company is headquartered in Seattle, WA. | Health Technology |
Coeptis Therapeutics Holdings, Inc. | |
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center Hospital/Nursing ManagementHealth Services Fred Hutchinson Cancer Center is a research and patient care institution that is committed to eradicating cancer and related diseases as causes of human suffering and death. The center conducts research and provides patient care of the highest standards to improve the prevention and treatment of cancer and related diseases. | Health Services |
- Bourse
- Insiders
- Colleen Delaney
- Expérience